Table 2 Demographic and clinical characteristics comparison between RSV and Non-RSV pediatric ARI cases.
Total pediatric ARI hospitalization cases during Jan 2010–Dec 2012 (n = 1854) | |||
|---|---|---|---|
RSV positive ARI group (n = 426) | Non-RSV ARI group (n = 1428) | p-value # | |
Total number (%)/Median (IQR ¶ ) | Total number (%)/Median (IQR ¶ ) | ||
Demographic information | |||
Male sex (%) | 254 (59.6%) | 799 (56.0%) | 0.179 |
Median age (in month) | 12 (IQR: 5–21) | 17 (IQR: 9–29) | <0.001*** |
Age group (%) | |||
0–12month | 218 (51.2%) | 528 (37.0%) | <0.001*** |
13–24month | 131 (30.8%) | 442 (31.0%) | |
25–36month | 52 (12.2%) | 187 (13.1%) | |
37–48month | 17 (4.0%) | 94 (6.6%) | |
49–60month | 2 (0.5%) | (4.3%) | |
>60month | 6 (1.4%) | 116 (8.1%) | |
Socioeconomic status | |||
Daycare attendance (%) | 137 (32.2%) | 552 (38.7%) | 0.015* |
History | |||
Antibiotic used prior to hospitalization (%) | 169 (39.7%) | 633 (44.3%) | 0.042* |
Underlying medical condition (%) | 133 (31.2%) | 541 (37.9%) | 0.012* |
Clinical information | Total number (%)/Mean (95% CI¶ ) | Total number (%)/Mean (95% CI¶ ) | |
Vital sign (s) | |||
Mean respiratory rate (per min) | 37.2 (95% CI: 36.3–38.1) | 35.7 (95% CI: 35.2–36.1) | 0.003** |
Mean body temperature (C.) | 37.9 (95% CI: 37.8–38.0) | 37.8 (95% CI: 37.8–37.9) | 0.045* |
SpO2 (≦90%) | 12 (2.8%) | 40 (2.8%) | 0.986 |
Respiratory symptom and sign (s) | |||
Wheeze (%) | 225 (52.8%) | 655 (45.9%) | 0.012* |
Tachypnea (%) | 132 (31.0%) | 301 (21.1%) | <0.001*** |
Difficulty breathing (%) | 51 (12.0%) | 157 (11.0%) | 0.575 |
Crackle (%) | 92 (21.6%) | 233 (16.3%) | 0.012* |
Cough (%) | 426 (100%) | 1423 (99.7%) | 0.221 |
Chest-wall indrawing (%) | 42 (9.9%) | 97 (6.8%) | 0.035* |
LRTI and chest X-ray result | |||
LRTI† (%) | 92 (21.6%) | 307 (21.5%) | 0.966 |
Mild LRTI (%) | 43 (10.1%) | 165 (11.6%) | 0.402 |
Severe LRTI § (%) | 49 (11.5%) | 142 (9.9%) | 0.353 |
Abnormal chest X-ray (%) | 62 (14.6%) | 210 (14.7%) | 0.856 |
Radiologically-confirmed pneumonia (%) | 55 (12.9%) | 182 (12.8%) | 0.991 |
Treatment and outcome (s) | |||
Mean onset to hospitalization (in day) | 2.4 (95% CI: 2.2–2.5) | 2.4 (95% CI: 2.2–2.5) | 0.831 |
Mean hospitalization duration (in day) | 5.2 (95% CI: 4.9–5.4) | 4.9 (95% CI: 4.7–5.1) | 0.132 |
Antibiotic used (%) | 426 (100%) | 1428 (100%) | 1.000 |
Steroid used (%) | 213 (50.0%) | 694 (48.6%) | 0.612 |